ProcartaPlex™ Human Immune Monitoring Panel, 65plex
ProcartaPlex™ Human Immune Monitoring Panel, 65plex
Citas y referencias (13)
Invitrogen™

ProcartaPlex™ Human Immune Monitoring Panel, 65plex

El panel 65-Plex ProcartaPlex de control inmunitario humano permite el estudio de la función inmune gracias al análisis de 65Más información
Have Questions?
Número de catálogoCantidad
EPX650-10065-90196 pruebas
Número de catálogo EPX650-10065-901
Precio (MXN)
-
Cantidad:
96 pruebas
El panel 65-Plex ProcartaPlex de control inmunitario humano permite el estudio de la función inmune gracias al análisis de 65 proteínas diana en un solo pocillo, mediante la tecnología Luminex xMAP. Analice 65 objetivos como la citoquina, la quimiocina y el factor de crecimiento simultáneamente para caracterizar la respuesta inmunitaria, detectar biomarcadores y realizar la validación. El panel se suministra en un formato listo para usar con viales individuales de reactivos de captura y detección formulados a una concentración 1X, que requieren menos pipeteo y configuración experimental. El kit no es compatible con el instrumento MAGPIX. Los usuarios de MAGPIX deben utilizar el panel de vigilancia inmunitaria humana 65 plex para MAGPIX (n.° de ref. EPX650-16500-901) que consta de dos kits independientes: uno de 43 y otro de 22 multiplexados, diseñados específicamente para usarse en el instrumento MAGPIX, que es capaz de detectar hasta 50 dianas simultáneamente.

Los paneles preconfigurados ProcartaPlex se han probado exhaustivamente para determinar la capacidad combinatoria, la interferencia y la reactividad cruzada de los analitos con el fin de proporcionar el mayor nivel de validación y precisión. Todos los paneles ProcartaPlex se suministran con los reactivos necesarios para realizar el ensayo.

Los paneles multiplex ProcartaPlex están disponibles en múltiples formatos en seis especies (humano, ratón, rata, primate no humano, porcino y canino).

Diana [región de gránulos]:
Citocinas: G-CSF (CSF-3) [42], GM-CSF [44], IFN alfa [48], IFN gamma [43], IL-1 alfa [62], IL-1 beta [18], IL-2 [19], IL-3 [73], IL-4 [20], IL-5 [21], IL-6 [25], IL-7 [26], IL-8 (CXCL8) [27], IL-9 [52], IL-10 [28], IL-12p70 [34], IL-13 [35], IL-15 [65], IL-16 [70], IL-17A (CTLA-8) [36], IL-18 [66], IL-20 [81], IL-21 [72], IL-22 [76], IL-23 [63], IL-27 [14], IL-31 [37], LIF [15], M-CSF [67], MIF [53], TNF alfa [45], TNF beta [54], TSLP [80]

Quiomicinas: BLC (CXCL13) [29], ENA-78 (CXCL5) [82], Eotaxin (CCL11) [33], Eotaxin-2 (CCL24) [37], Eotaxin-3 (CCL26) [77], Fractalkine (CX3CL1) [59], GRO-alfa (CXL1) (CXCL1) [61], IP-10 (CXCL10) [22], I-TAC (CXCL11) [57], MCP-1 (CCL2) [51], MCP-2 (CCL8) [8], MCP-3 (CCL7) [68], MDC (CCL22) [87], MIG (CXCL9) [69], MIP-1 alfa (CCL3) [12], MIP-1 beta (CCL4) [47], MIP-3 alfa (CCL20) [56], SDF-1 alfa (CXCL12) [13]

Factores de crecimiento/reguladores: FGF-2 [75], HGF [46], MMP-1 [64], NGF beta [55], SCF [39], VEGF-A [78]

Receptores solubles: APRIL [88], BAFF [86], CD30 [84], CD40L (CD154) [74], IL-2R (CD25) [22], TNF-RII [85], TRAIL (CD253) [58], TWEAK [97]

Acerca de los ensayos ProcartaPlex para la plataforma Luminex
Los inmunoensayos ProcartaPlex se basan en los principios de un ELISA tipo sándwich. Utilizan dos anticuerpos altamente específicos que se enlazan a diferentes epítopos de una proteína para cuantificar todas las proteínas diana de forma simultánea, mediante el uso de un instrumento Luminex. Para los ensayos ProcartaPlex multiplex se requieren tan solo 25 µl de plasma o suero, o 50 µl de sobrenadante del cultivo celular, y solo se necesitan cuatro horas para obtener los resultados analizados.

Las características incluyen:
• Resultados reproducibles y fiables: validados como panel según el estándar más alto del sector. Incluye pruebas de combinación de proteínas diana y reactividad cruzada
• Más resultados por muestra: mida múltiples proteínas diana simultáneamente en una única muestra de 25–50 µl
•Tecnología Luminex consolidada: plataforma de multiplexing de referencia para detección y cuantificación de proteínas

Los ensayos de ProcartaPlex utilizan la tecnología Luminex xMAP (perfil multianálito) para la detección y cuantificación simultáneas de hasta 65 proteínas diana en una sola muestra de plasma, suero, sobrenadantes de cultivo celular y otros fluidos corporales de 25–50 µl.
Para uso exclusivo en investigación. No apto para uso en procedimientos diagnósticos.
Especificaciones
Intervalo del ensayoVer certificado de análisis
Sensibilidad del ensayoMenos del 15 %
Método de detecciónFluorescente
Para utilizar con (equipo)Instrumentos Luminex™
FormatoKit multiplex
Línea de productosProcartaPlex
Tipo de muestraSobrenadantes de cultivo celular, suero y plasma, Plasma, Cell Culture Supernatants
Volumen de muestraSuero, plasma: 25 μl; CCS: 50 μl
Condiciones de envíoHielo húmedo
CombinabilityNo combinable
Tipo de productoPanel de multiplexado
Cantidad96 pruebas
Research AreaImmunology
EspecieHumano
Unit SizeEach
Contenido y almacenamiento
  • 2 viales de mezcla estándar humana M (liofilizada)
  • 1 vial de mezcla de gránulos de captura (1X)
  • 1 vial de mezcla de anticuerpos de detección biotinilada (1X)
  • 2 viales de control alto humano alto
  • 2 viales de control alto humano bajo
  • 1 frasco de tampón de lectura (1X)
  • 1 frasco de tampón de lavado (10X)
  • 1 frasco de estreptavidina-PE (1X)
  • 1 frasco de tampón de ensayo universal (1X)
  • Tira de 8 tubos
  • Película adhesiva
  • Placa de 96 pocillos de fondo plano, negra
  • Almacenar entre 2 °C y 8 °C

Preguntas frecuentes

What is the size of the Luminex beads you currently use?

The beads used in our Luminex instrument-compatible ProcartaPlex and QuantiGene Plex assays are 6.5 micron superparamagnetic beads.

Find additional tips, troubleshooting help, and resources within our Protein Assays and Analysis Support Center.

I am interested in performing Luminex assays using BioSource kits, and I have a Luminex xMAP system. Besides the kits and system, what other reagents and equipment will I need?

The following is a list of general lab supplies that are required for running BioSource immunoassays on the Luminex xMAP system:
1) Sonicating water bath
2) Orbital shaker
3) Vortexer
4) Repeating and/or multi-channel pipetter (not required, but recommended)
5) Calibrated adjustable precision pipettes, with disposable plastic tips
6) Glass/plastic tubes and racks for preparing reagents
7) Graduated cylinder and container for preparing wash solution
8) Aluminum foil
9) Deionized or distilled water.

Find additional tips, troubleshooting help, and resources within our Protein Assays and Analysis Support Center.

Do the Luminex beads require special care in handling?

The Luminex beads should be protected from light because they are susceptible to photobleaching. We recommend protecting the beads by keeping containers covered with aluminum foil during all incubation steps, and exercising care during handling. The beads should not be frozen, subjected to excessive heat, or exposed to organic solvents.

Find additional tips, troubleshooting help, and resources within our Protein Assays and Analysis Support Center.

Why would the Luminex acquisition software display "Sample Empty" messages during analysis?

(1) The user did not properly aliquot the diluted beads, such that no beads were actually added to the wells (make sure that the bead concentrates are sonicated and vortexed well, then check the pipet tip to ensure that air bubbles were not drawn up)
(2) The user missed loading diluted beads to some wells, which is likely since the small volume is clear and difficult to visualize in the clear plastic plate (we have now addressed this customer difficulty by coloring each of the Buffer Reagent Kit components)
(3) The user applied too much vacuum pressure at some point during the wash steps, or allowed the pressure to spike even once, such that the filter membrane tore in a few wells releasing the beads (make sure that the vacuum manifold pressure is kept below 5mm/in Hg, depending on their system -- a good rule of thumb is that it should take a full 3-second count to GENTLY empty the wells of 200uL)
(4) The user did not properly sonicate and vortex the beads prior to dilution, such that the percent of bead aggregation was high and the instrument was unable to find enough single beads to meet the events/bead value designated by the customer (make sure that the Bead Concentrate tube is put into the waterbath all the way to the cap, since the tube is hollow until the top third)
(5) The user lost beads by shaking the plate too aggressively or handling it improperly (make sure that the orbital shaker is set to a speed that allows for maximum vortex in the wells without spillage)
(6) The user exposed the beads to an excess of light during storage or running of the assay, such that some but not all of the beads were photobleached and therefore falling outside the acceptable range for each bead region (make sure that the plate is covered on the top/sides with foil throughout the assay, away from Windows and spotlights, and that the bead component of the kits is stored in the dark)*
(7) There was a clog in the sample needle, such that the instrument was unable to take up enough sample to meet the number of events requested per bead region (suggest that the user follow the manual instructions for dislodging a clog, which include several Back Flush steps and may require removal of the needle for sonication with probe alignment).

* Some of the older Antibody Bead Kits still have clear plastic tops instead of black ones. In cases where customers store kits in lit refrigerators, or keep them open on the lab bench, even a few hours of light exposure is enough to photobleach beads. It is important to note, in general, that higher number bead regions are more susceptible to photobleaching. In order to draw conclusions about the source of the difficulty, we would ask to see the data, specifically the Masterplex QT file, which would enable us to examine the pattern of "Sample Empty" occurrences in addition to the bead counts per well.

Find additional tips, troubleshooting help, and resources within our Protein Assays and Analysis Support Center.

What are the Luminex beads made of?

The beads are made of polystyrene.

Find additional tips, troubleshooting help, and resources within our Protein Assays and Analysis Support Center.

View all ProcartaPlex™ Human Immune Monitoring Panel, 65plex FAQs

Citations & References (13)

Citations & References
Abstract
No Distinct Cytokine, Chemokine, and Growth Factor Blood Profile Associated With Monkeypox Virus Clade IIb Infected Patients.
Authors:Bangwen E,Berens-Riha N,de Vrij N,Ceulemans A,Brosius I,De Vos E,Pham TT,Bottieau E,van Griensven J,Netongo PM,Van Esbroeck M,Vercauteren K,Van Dijck C,Adriaensen W,Liesenborghs L
Journal:Journal of medical virology
PubMed ID:40156483
Previous studies indicated Clade I monkeypox virus infection to be associated with marked elevation of proinflammatory cytokines. This remains unexplored for Clade II‐associated disease, which has different clinical manifestations and prognosis. We used a 65‐plex cytokine, chemokine, and growth factor (CCG) panel to analyze serum samples of 100 male acute ... More
Immune monitoring of trabectedin therapy in refractory soft tissue sarcoma patients - the IMMUNYON study.
Authors:Rodrigues-Santos P,Almeida JS,Sousa LM,Couceiro P,Martinho A,Rodrigues J,Fonseca R,Santos-Rosa M,Freitas-Tavares P,Casanova JM
Journal:Frontiers in immunology
PubMed ID:40007535
Soft tissue sarcomas (STS) encompass over 50 histologic subtypes, representing more than 1% of solid tumors. Standard treatments include surgical resection and therapies such as anthracyclines or trabectedin for advanced cases, though challenges persist due to the tumor microenvironment’s complexity and limited immune profiling data. This study evaluates Trabectedin therapy ... More
Immune profiling of human vestibular schwannoma secretions identifies TNF-α and TWEAK as cytokines with synergistic potential to impair hearing
Authors:Vasilijic S, Seist R, Yin Z, Xu L, Stankovic KM
Journal:Journal of Neuroinflammation
PubMed ID:39923035
Vestibular schwannoma (VS) is an intracranial tumor arising from the Schwann cells of the vestibular nerve and is an important cause of sensorineural hearing loss (SNHL) in humans. The mechanisms underlying this SNHL are incompletely understood and currently, there are no drugs FDA approved specifically for VS. This knowledge gap ... More
Assessing serum cytokine profiles in inflammatory breast cancer patients using Luminex® technology.
Authors:Yaacoubi-Loueslati B
Journal:Cytokine
PubMed ID:37918053
Inflammatory breast cancer (IBC), accounts for the majority of deaths associated with breast tumors. Because this form is aggressive from its appearance and has a strong metastatic potential. The majority of patients are not diagnosed until late stages, highlighting the need for the development of novel diagnostic biomarkers. Immune mediators ... More
Multiplexing protein and gene level measurements on a single Luminex platform.
Authors:Cook DB, McLucas BC, Montoya LA, Brotski CM, Das S, Miholits M, Sebata TH
Journal:Methods
PubMed ID:30742996
'The ability to simultaneously measure multiple secreted proteins and the corresponding gene expression levels from a single sample is valuable for comprehensive analysis. Bottlenecks to traditional immunoassays and gene expression assays include large sample consumption, time consuming experimental procedures, and complex data analysis.' ... More
View all ProcartaPlex™ Human Immune Monitoring Panel, 65plex citations